Test Product (tiotropium bromide inhalation powder)

COMBINATION_PRODUCT2 trials

Sponsors

Lupin, Inc., Phargentis SA

Conditions

COPDChronic Obstructive Pulmonary Disease

Phase 3

Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness

CompletedNCT03137992

Lupin, Inc.Chronic Obstructive Pulmonary Disease

Start: 2017-11-21End: 2018-04-30Updated: 2021-04-05

Bioequivalence Study of Tiotropium Bromide Inhalation Powder

CompletedNCT05161156

Phargentis SACOPD

Start: 2022-03-24End: 2022-11-29Updated: 2023-04-10